Medical specialists from Belgium tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 30 results
-
Adriano SalaroliSeen in:
- Brussels, BE-Brussel-BORDET
Trials:- NCT04027309 (Principal Investigator)
-
Anne Uyttebroeck, MD, PhDSeen in:
- Leuven, University Hospital Leuven
- Vl Brabant, Leuven, UZ Leuven , pediatric oncology
Trials:- NCT05477589 (Principal Investigator)
- NCT02309242 (Principal Investigator)
-
Bernard De PrijckSeen in:
- Liège, BE-Liege-CHULIEGE
Trials:- NCT04027309 (Principal Investigator)
-
Carlos GrauxSeen in:
- Namur, Yvoir, CHU - UCL Namur site Godinne
- Yvoir, BE-Yvoir-MONTGODINNE
- Yvoir, CHU-UCL Namur
Trials:- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Caroline JacquySeen in:
- Henegouwen, Mons, CHU Ambroise Pare
- Mons, BE-Mons-AMBROISE
Trials:- NCT04027309 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Cécile Boulanger, MD, PhDSeen in:
- Brussels, Cliniques Universitaires Saint-Luc (CUSL)
Trials:- NCT05477589 (Principal Investigator)
-
Dimitri BreemsSeen in:
- Antwerpen, BE-Antwerpen-ZNASTUIVENBERG
Trials:- NCT04027309 (Principal Investigator)
-
Dominik SelleslagSeen in:
- Brugge, A.Z. Sint-Jan
- Brugge, BE-Brugge-AZBRUGGE
- West Vlaanderen, Brugge, AZ Sint Jan Brugge
Trials:- NCT04027309 (Principal Investigator)
- NCT04053933 (Principal Investigator)
- NCT00838240 (Principal Investigator)
-
Dominique BronSeen in:
- Brussel, Institut Jules Bordet
Trials:- NCT00838240 (Principal Investigator)
Conditions: -
Dries DEEREN, MDSeen in:
- Roeselare, AZ Delta
Trials:- NCT04167696 (Principal Investigator)
Conditions: -
Evelyne Willems, MDSeen in:
- Liege, CHU Sart Tilman
- Liège, CHU Liege
- Liège, CHU de Liege
- Liège, Centre Hospitalier Régional de la Citadelle (CHR)/CHU Liège
Trials:- NCT03083574 (Sub-Investigator)
- NCT00603330 (Sub-Investigator)
- NCT03852407 (Sub-Investigator)
- NCT05477589 (Principal Investigator)
Conditions:- Refractory Chronic Graft Versus Host Disease (cGVHD);
- Graft-versus-host Disease;
- Poor Graft Function;
- Low Donor T-cell Chimerism;
- Myelodysplastic Syndromes;
- Multiple Myeloma;
- Hodgkin Lymphoma;
- Non Hodgkin Lymphoma;
- Myeloproliferative Disorder;
- Chronic Lymphoid Leukemia;
- Acute Myeloid Leukemia in Remission;
- Myeloproliferative Syndrome;
- Chronic Myeloid Leukemia in Remission;
- Acute Lymphoid Leukemia in Remission;
- Stem Cell Transplantation;
- Acute Myeloid Leukemia (AML) in Remission
-
Evelyne WILLENS, DrSeen in:
- Liège, CHU Liege
Trials:- NCT03887156 (Sub-Investigator)
-
Florence ObberghSeen in:
- Haine-Saint-Paul, BE-Haine-Saint-Paul-JOLIMONT
Trials:- NCT04027309 (Principal Investigator)
-
Frédéric BARON, DrSeen in:
- Liège, CHU Liege
Trials:- NCT03887156 (Sub-Investigator)
-
Hélène Schoemans, MD PhDSeen in:
- Leuven, UZ Leuven
Trials:- NCT03852407 (Sub-Investigator)
-
Ine MoorsSeen in:
- Gent, BE-Gent-UZGENT
Trials:- NCT04027309 (Principal Investigator)
-
Ka Lung WUSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Liesbet LammertijnSeen in:
- Hasselt, BE-Hasselt-VIRGAJESSE
Trials:- NCT04027309 (Principal Investigator)
-
Marie-Christiane VekemansSeen in:
- Brussels, BE-Bruxelles-STLUC
- Vlaams Brabant, Woluwe-Saint-Lambert, Cliniques Universitaires Saint-Luc
Trials:- NCT04027309 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Nikki GRANACHERSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Pauline Mazilier, MD, PhDSeen in:
- Brussels, L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Trials:- NCT05477589 (Principal Investigator)
-
Philippe Martiat, MD PhDSeen in:
- Brussels, Institut Jules Bordet, tumor center of the Universite Libre de Bruxelles
Trials:- NCT01513109 (Principal Investigator)
-
Rik Schots, MD PhDSeen in:
- Brussels, UZ Brussel
Trials:- NCT03852407 (Sub-Investigator)
-
Sophie SERVAIS, DrSeen in:
- Liège, CHU Liege
- Liège, CHU de Liege
Trials:- NCT03887156 (Sub-Investigator)
- NCT03852407 (Sub-Investigator)
Conditions:- Acute Lymphoblastic Leukemia;
- Acute Myeloid Leukemia in Remission;
- Lymphoma in Remission;
- Non-progressive Myeloproliferative Syndrome;
- Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts;
- Acute Leukemia Biphenotypic in Remission;
- Myelodysplastic Syndromes;
- Multiple Myeloma;
- Hodgkin Lymphoma;
- Non Hodgkin Lymphoma;
- Myeloproliferative Disorder;
- Chronic Lymphoid Leukemia;
- Myeloproliferative Syndrome;
- Chronic Myeloid Leukemia in Remission;
- Acute Lymphoid Leukemia in Remission
-
Tom EYCKMANSSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Victoria Bordon, MD, PhDSeen in:
- Ghent, Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital
Trials:- NCT05477589 (Principal Investigator)
-
YVES BEGUIN, MDSeen in:
- Liège, CHU Liege
Trials:- NCT04167696 (Principal Investigator)
Conditions: -
Zwi N Berneman, MD, PhDSeen in:
- Antwerp, Antwerp University Hospital
Trials:- NCT01686334 (Principal Investigator)
Conditions:
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States